We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$16.3B
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
-2.91%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$14.1B
AUM Growth
+$741M
(+5.6%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49
Avg Time Held
14.1
quarters
Top 10 Avg Time Held
19
quarters
Top 20 Avg Time Held
14.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$110M |
| 2 |
Apple
AAPL
|
+$89M |
| 3 |
Microsoft
MSFT
|
+$81.1M |
| 4 |
Amazon
AMZN
|
+$54.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$45.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$4.8M |
| 2 |
KeyCorp
KEY
|
+$4.08M |
| 3 |
Solstice Advanced Materials
SOLS
|
+$3.06M |
| 4 |
Valero Energy
VLO
|
+$2.61M |
| 5 |
Monster Beverage
MNST
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Financials | 11.04% |
| 3 | Consumer Discretionary | 10.62% |
| 4 | Communication Services | 10.59% |
| 5 | Healthcare | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MRX
1426
Marex Group Limited Ordinary Shares
MRX
$5.2B
| $222K | ﹤0.01% |
+4,990
| New | +$197K |
2026 Q1
0 quarters
|
|
1427
Benchmark Electronics
BHE
$2.85B
| $222K | ﹤0.01% |
+3,954
| New | +$213K |
2026 Q1
0 quarters
|
|
1428
Dyne Therapeutics
DYN
$2.98B
| $221K | ﹤0.01% |
+12,208
| New | +$211K |
2026 Q1
0 quarters
|
|
1429
Mercury Insurance
MCY
$5.69B
| $221K | ﹤0.01% |
+2,505
| New | +$224K |
2026 Q1
0 quarters
|
|
1430
Sanofi
SNY
$95.2B
| $219K | ﹤0.01% |
+4,550
| New | +$212K |
2026 Q1
0 quarters
|
|
1431
Andersons Inc
ANDE
$2.21B
| $219K | ﹤0.01% |
+3,045
| New | +$196K |
2026 Q1
0 quarters
|
|
1432
Amneal Pharmaceuticals
AMRX
$6.98B
| $218K | ﹤0.01% |
17,556
+5,706
| +48% | +$76.6K |
2024 Q2
7 quarters
|
|
1433
Korea Electric Power
KEP
$13.6B
| $218K | ﹤0.01% |
+15,285
| New | +$289K |
2026 Q1
0 quarters
|
|
1434
BancFirst
BANF
$3.6B
| $217K | ﹤0.01% |
+1,997
| New | +$222K |
2026 Q1
0 quarters
|
|
1435
First Bancorp
FBNC
$2.47B
| $217K | ﹤0.01% |
+3,845
| New | +$219K |
2026 Q1
0 quarters
|
|
1436
Beam Therapeutics
BEAM
$2.6B
| $216K | ﹤0.01% |
9,069
+1,495
| +20% | +$41.5K |
2025 Q4
1 quarter
|
|
1437
Verra Mobility
VRRM
$444M
| $216K | ﹤0.01% |
15,112
+2,489
| +20% | +$45.6K |
2024 Q1
8 quarters
|
|
1438
OneSpaWorld
OSW
$2.42B
| $215K | ﹤0.01% |
+9,388
| New | +$200K |
2026 Q1
0 quarters
|
|
1439
FB Financial Corp
FBK
$2.65B
| $215K | ﹤0.01% |
+4,147
| New | +$233K |
2026 Q1
0 quarters
|
|
1440
Artisan Partners
APAM
$2.3B
| $215K | ﹤0.01% |
5,916
+949
| +19% | +$38.8K |
2025 Q2
3 quarters
|
|
1441
Newmark Group
NMRK
$2.13B
| $215K | ﹤0.01% |
14,310
+2,711
| +23% | +$42.8K |
2025 Q1
4 quarters
|
|
1442
DNOW Inc
DNOW
$2.74B
| $214K | ﹤0.01% |
18,000
+2,927
| +19% | +$39.6K |
2025 Q4
1 quarter
|
|
1443
Tango Therapeutics
TNGX
$4.08B
| $214K | ﹤0.01% |
+10,238
| New | +$143K |
2026 Q1
0 quarters
|
|
1444
ImmunityBio
IBRX
$10.7B
| $214K | ﹤0.01% |
27,849
+4,681
| +20% | +$32K |
2025 Q1
4 quarters
|
|
1445
Ziff Davis
ZD
$1.97B
| $213K | ﹤0.01% |
5,076
-2,689
| -35% | -$98.9K |
2025 Q3
2 quarters
|
|
1446
Minerals Technologies
MTX
$1.96B
| $212K | ﹤0.01% |
+2,993
| New | +$206K |
2026 Q1
0 quarters
|
|
1447
Novo Nordisk
NVO
$170B
| $212K | ﹤0.01% |
5,772
+1,424
| +33% | +$67.5K |
2023 Q3
10 quarters
|
|
1448
The Bancorp
TBBK
$2B
| $212K | ﹤0.01% |
3,937
+613
| +18% | +$36.7K |
2025 Q2
3 quarters
|
|
1449
Boston Beer
SAM
$1.8B
| $212K | ﹤0.01% |
+918
| New | +$206K |
2026 Q1
0 quarters
|
|
1450
NBT Bancorp
NBTB
$2.62B
| $210K | ﹤0.01% |
+4,934
| New | +$214K |
2026 Q1
0 quarters
|
|
Similar funds
PCM
LPC
MFG
PAM
BS
BBVA
NMO
PAS
Xponance's Q1 2026 Portfolio in Review
As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.
- Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
- Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
- Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
- Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
- Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
- Xponance opened 165 new positions and closed 49 in Q1 2026.
- Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.